Abstract
Anticancer drug discovery has evolved significantly in recent decades, thanks to advancements in biotechnology. The development of novel anticancer agents is driven by a deeper understanding of cancer biology, molecular targets, and the role of genetic mutations in cancer progression. Biotechnology techniques, including genomics, proteomics, and cell-based assays, have enabled the identification of new drug targets and the design of more effective therapies. This article explores the role of biotechnology in anticancer drug discovery, focusing on the use of biotechnology for identifying molecular targets, designing drug candidates, and developing personalized cancer therapies. It also discusses the challenges, successes, and future directions in anticancer drug development.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2022 Dr. Victoria Harris, Dr. William Green (Author)